Registration Info

This is a 1-day meeting and will provide 6 CE/CME credits.

Conference Registration Fee

Practicing Healthcare Professionals: $129

Non-Clinicians / Medical Office Support Staff / Industry Participants

In order to maintain the clinical nature of the conference, nonclinicians—including, but not limited to, office managers, billing specialists, receptionists, and administrative staff; guests, spouses, friends, and/or family members—may not attend PAINWeekEnd.


Unfortunately, we do not have discounts available on hotel rooms. Please contact the hotel directly should you require accommodations.

The Westin Southfield Detroit
1500 Town Center
Southfield, MI 48075

View hotel website >>


Get Directions using Google Maps


Faculty and courses are subject to change. Please refer to the online agenda below for the most recent course descriptions.

To view the agenda below, click on the + sign next to the day of the conference to expand the conference agenda. Click on the + signs within the agenda to view the course description, UAN number, and AANP pharmacology credits.

*not certified for credit

Saturday, November 9, 2019


    Coffee will be served.

  • Falling Down the Rabbit Hole: A Primer for Chronic Pain Management and Substance Abuse Disorders

    The field of pain management has undergone a circuitous adventure, much like a rabbit hole. As the economic, mental health, and medical consequences of prescribing opioid medications have mounted, the prevailing logic regarding the usefulness of prescribing opioids for chronic pain has shifted. The widespread dissemination of opiates and the lax safety measures placed on their storage has also led to an increase in nonmedical use. Given the high level of comorbidity between opioid use disorders and chronic pain, providers’ decisions about how to address treatment with patients who may have or who have been diagnosed with substance use disorders are often complex. The new CDC guidelines will require providers to assess for risk of overdose or development of a substance use disorder, and to be keenly aware of their patients’ pain levels and pain management strategies when working as part of a system where opioid medications may be prescribed. Participants will learn how patient and provider education programs and communication interventions may improve outcomes in pain management. Participants will also learn how to select candidates for opioid trials, assess for risk, and initiate opioid therapy, but only after exploring nonopioid and nonpharmacological strategies.

    • UAN: 0530-0000-19-055-L01-P
    • AANP Rx Hours: 0.00
  • CME Breakfast - Reefer Madness Revisited: Taking the Insanity Out of Medical Cannabinoids

    Medical, and recreational, marijuana serve as sources of great confusion to patients and clinicians alike. A culture of “neuromysticism” around medical marijuana has arisen, leaving patients and clinicians alike confused regarding what constitutes “medical” marijuana. A part of this confusion is related to the poor quality of the available research on safety and efficacy, which are due, in part, to the restrictive scheduling of the drug. This lecture will focus on what we know, and what we don’t know, about the efficacy and safety of medical cannabinoids. Specific recommendations regarding the safest and most effective use of medical marijuana as part of a pain management armamentarium will be provided.

    Breakfast will be served.

    • UAN: 0530-0000-19-049-L04-P
    • AANP Rx Hours: 0.00

  • What's All the "GABA" About? Pregabalin and Gabapentin Abuse

    The gabapentinoids are a popular class of medications among prescribers for use in chronic pain and various other neurological conditions. In fact, prescription rates for both gabapentin and pregabalin have increased in the United States and other countries in recent years. However, these medications have a street value to a newer niche of users, including patients taking them at megadoses to enhance the effects of other psychotropic drugs, and other patients taking them to manage or mitigate opioid withdrawal symptoms and possibly even opioid cravings. While pregabalin is already classified as a controlled substance, gabapentin does not yet carry this classification. In response to rising abuse, various states and regulatory bodies are considering changes to enhance patient safety and protect the provider’s license. Learn what changes you should make to your practice, if any, in light of the growing abuse of gabapentinoids and how to identify patients potentially abusing them.

    • UAN: 0530-0000-19-044-L01-P
    • AANP Rx Hours: 0.00
  • Opioid Moderatism: Seeking Middle Ground

    Few would question the severity of the prescription opioid crisis of the early years of this millennium, the causes of which were myriad. Undoubtedly, society needed to address the crisis in an aggressive manner. Unfortunately, the manner in which the problem was addressed has been a classic example of “overkill,” resulting in a war on opioid analgesia, the patients who require opioid treatment, and the providers who have continued to prescribe. Although many have cast blame on the 2016 CDC Opioid Prescribing Guideline, it was not necessarily the Guideline itself that caused so much suffering, but rather its weaponization. Irrespective, patients have been the “collateral damage” in this war on opioids. This presentation will address the imperative of physicians exercising more thorough and consistent opioid risk mitigation in order to avoid opioid analgesia from becoming further “legislated away,” as well as the imperative of those who are “pro-opioid” and “anti-opioid” to agree on a rational middle ground that is more “pro-patient.”

    • UAN: 0530-0000-19-047-L01-P
    • AANP Rx Hours: 0.00



    Lunch will be served.

    Sponsored by Legally Mine.

  • Precise Prescribing: Applying the Science of Pain to Treatment Decisions

    Appropriate prescribing for acute and chronic pain in the midst of the opioid epidemic requires a strong knowledge of pain pathways and underlying mechanisms to optimize treatment decision-making. This symposium will integrate 3D modeling to bring pain and addiction mechanisms to life in order to promote a better understanding of evolving pain management strategies. Faculty will provide best practice strategies for the clinical assessment and management of acute and chronic pain aligned to supporting evidence and recommendations to guide safe and effective pharmacological and nonpharmacologic treatment choices.

    Presented by CME Outfitters and USF Health. Supported by an educational grant from Johnson & Johnson.

    • UAN: 0376-0000-19-015-L01-P

  • The Gentle Art of Saying No: How to Establish Appropriate Boundaries With Chronic Pain Patients

    Effective pain management has been deemed a human right, but some chronic pain patients perceive that to mean they are entitled to opioid analgesics for prolonged pain control. In response to these expectations, providers may feel pressured to say “Yes” and continue prescribing opioids, thereby reinforcing the patient’s beliefs and reliance on medication. This has contributed to a dramatic rise in opioid analgesic misuse and deaths from prescription drug overdose. In fact, the CDC has identified opioid misuse as a “public health epidemic” and released new guidelines in March 2016. While a collaborative relationship is optimal for pain management, there may be times when a practitioner saying “No” is the best treatment. Many providers feel uncomfortable setting boundaries; however, boundary setting is important work because rights as a provider are also important. When reasonable limits are placed on a patient and the patient continues to step beyond those limits, it is imperative that providers maintain boundaries and be consistent in their message. Participants will learn about the gentle art of saying “No” and how to use a decision tree when making pain management decisions. Sample cases will be presented along with recommended treatment strategies.

    • UAN: 0530-0000-19-058-L01-P
    • AANP Rx Hours: 0.00


To accompany and enrich your experience at the PAINWeekEnd conference, be sure to attend one or more of the sponsored programs, which are scheduled during breakfast, lunch, and afternoon "Brain Food" time slots in the schedule. There is NO ADDITIONAL CHARGE to attend these program sessions!